| 注册
首页|期刊导航|中国临床药理学杂志|聚乙二醇洛塞那肽治疗肥胖型2型糖尿病患者轴状胃切除术患者的临床研究

聚乙二醇洛塞那肽治疗肥胖型2型糖尿病患者轴状胃切除术患者的临床研究

谷敬锋 刘海霞 冯峰 张建 邢东洋 高昊雯 王桂琦

中国临床药理学杂志2024,Vol.40Issue(3):330-334,5.
中国临床药理学杂志2024,Vol.40Issue(3):330-334,5.DOI:10.13699/j.cnki.1001-6821.2024.03.006

聚乙二醇洛塞那肽治疗肥胖型2型糖尿病患者轴状胃切除术患者的临床研究

Clinical trial of pegylated losenatide in the treatment of obese patients with type 2 diabetes mellitus undergoing axial gastrectomy

谷敬锋 1刘海霞 2冯峰 1张建 1邢东洋 1高昊雯 1王桂琦1

作者信息

  • 1. 河北医科大学第一医院减重与代谢外科,河北石家庄 050011
  • 2. 河北医科大学第一医院普外科,河北石家庄 050011
  • 折叠

摘要

Abstract

Objective To observe the effects of pegylated losenatide injection combined with metformin tablets on serum metabolism,lipid levels and intestinal flora in obese type 2 diabetes mellitus(T2DM)patients after axial gastrectomy.Methods Obese T2DM patients who underwent axial gastrectomy were divided into treatment group and control group by cohort methods.The control group was treated with metformin hydrochloride tablet 0.5 g orally,tid.The treatment group was treated by subcutaneous injection of pegylated losenatide injection 0.2 mg once a week on the basis of control group.Both groups were treated continuously for 3 months.Body mass index(BMI),serum metabolic indexes,blood lipid levels,blood glucose levels,intestinal flora and adverse drug reactions were compared between the two groups.Results In this study,a total of 70 subjects were included in the treatment group,and 50 subjects were included in the control group.After three months of treatment,the BMI indices of the treatment and control groups were(26.35±2.36)and(29.34±3.59)kg·m-2,respectively;the glutathione peroxidase levels were(192.42±13.18)and(134.27±12.86)U;interleukin-6 levels were(6.14±1.78)and(7.65±2.09)μg·L-1;fasting blood glucose levels were(5.36±0.41)and(7.43±0.78)mmol·L-1;total cholesterol levels were(2.55±0.67)and(3.47±0.79)mmol·L-1 for the treatment and control groups,respectively.The levels of Bifidobacteria,Bacteroides,Lactobacilli,Enterobacteria,and Enterococci in the treatment group were(8.79±1.36),(9.62±1.37),(6.74±2.15),(7.98±0.61),and(7.23±1.29)logN·g-1,respectively;in the control group,these levels were(7.98±1.79),(8.13±1.45),(5.71±2.41),(9.21±0.88),and(8.15±1.54)logN·g-1.The differences in the above indicators between the treatment and control groups were statistically significant(all P<0.05).The main adverse drug reactions in the treatment group included nausea,headache,dizziness,elevated blood pressure,and indigestion.In the control group,the main adverse drug reactions were nausea,headache,and indigestion.The total incidence of adverse drug reactions in the treatment and control groups was 8.57%and 6.00%,respectively,with no statistically significant difference(P>0.05).Conclusion Pegylated losenatide injection combined with metformin tablets has a significant effect on axial gastrectomy in obese type 2 diabetes patients.

关键词

聚乙二醇洛塞那肽注射液/二甲双胍片/肥胖型2型糖尿病/血清代谢/血脂/肠道菌群

Key words

pegylated losenatide injection/metformin tablet/obese type 2 diabetes mellitus/serum metabolism/blood lipid/intestinal flora

分类

医药卫生

引用本文复制引用

谷敬锋,刘海霞,冯峰,张建,邢东洋,高昊雯,王桂琦..聚乙二醇洛塞那肽治疗肥胖型2型糖尿病患者轴状胃切除术患者的临床研究[J].中国临床药理学杂志,2024,40(3):330-334,5.

中国临床药理学杂志

OA北大核心CSTPCD

1001-6821

访问量2
|
下载量0
段落导航相关论文